TCR clonotypes are largely distinct between Foxp3− and Foxp3+ CD4+ tumor-infiltrating T cell sub-populations, indicating that conversion does not account for intra-tumoral Treg-enrichment and supporting the hypothesis that Tregs within the tumor are thymus-derived Tregs (tTregs) [17]. The gene discussed is CD4; the disease is neoplasm.